Expression and significance of TGF-β1/Smad signaling pathway in children with IgA nephropathy
Authors:
- 20 August 2009
- journal article
- research article
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 5 (3) , 211-215
Abstract
Background IgA nephropathy (IgAN) exhibits an indolent but slowly progressive course, and about 30% of children with IgAN are found to deteriorate to end-stage renal failure characterized by overaccumulation of extracellular matrix, diffuse glomerular sclerosis, and tubulointerstitial fibrosis. The TGF-β/Smad signaling pathway plays an important role in glomerulosclerosis and tubulointerstitial fibrosis. The present study aimed to elucidate the significance of expressions of TGF-β1, phosphorylated Smad3 (p-Smad3), Smad7 and fibronectin (FN) in the renal tissue of children with IgAN. Methods Forty-six children with IgAN were divided into 3 groups according to their clinical features: isolated hematuria group (IH group, 8 patients), hematuria and proteinuria group (HP group, 24), and nephritic syndrome group (NS group, 14). Patients were also divided into three groups according to their pathologic grade: grade I+II (22 patients), grade III (12) and grade IV (12) groups. Five normal renal specimens were used as the control group. The expression of TGF-β1, p-Smad3, Smad7 and FN in renal biopsy specimens was detected by two-step PowerVision™. The degrees of renal tubular injury and interstitial fibrosis were scored according to the Katafuchi semi-quantitative criteria. Results The expression of TGF-β1, p-Smad3, Smad7 and FN in children with IgAN was significantly higher than that in the control group (in glomeruli: PPPPPPPPPPP<0.05). Conclusion The TGF-β1/Smad signaling pathway plays an important role in the progress of glomerular sclerosis, renal tubular injury and interstitial fibrosis in children with IgAN.Keywords
This publication has 11 references indexed in Scilit:
- Improved renal survival in Japanese children with IgA nephropathyPediatric Nephrology, 2008
- Pediatric IgA Nephropathy: Clinical and Therapeutic PerspectivesSeminars in Nephrology, 2008
- Localization of TGF-β Signaling Intermediates Smad2, 3, 4, and 7 in Developing and Mature Human and Mouse KidneyJournal of Histochemistry & Cytochemistry, 2007
- Peroxisome Proliferator-Activated Receptor-γ Ligands Inhibit TGF-β1-Induced Fibronectin Expression in Glomerular Mesangial CellsDiabetes, 2004
- [The expressions of TGF-beta1 and Smad 2 mRNA on diseased glomeruli and their significance in the development of glomerulosclerosis].2002
- Blockade of the Effects of TGF-β1 on Mesangial Cells by Overexpression of Smad7Journal of the American Society of Nephrology, 2002
- It's a Smad world: regulation of TGF-beta signaling in the kidney.2002
- Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation.1998
- Expression of transforming growth factor-β isoforms in human glomerular diseasesKidney International, 1996
- Growth factors from murine sarcoma virus-transformed cells.Proceedings of the National Academy of Sciences, 1978